2nd Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| NADEAM ELSHAMI | — |
| EMILY FELDER New | Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee |
| MARC LAMPKIN | — |
| BRIAN MCKEON | — |
| JEROME MURRAY | — |
| ZACHARY PFISTER | — |
| BRIAN WILD | — |
Environment/Superfund ENV
Issues related to corporate environmental sustainability
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| NADEAM ELSHAMI | — |
| BRIAN MCKEON | — |
| JEROME MURRAY | — |
| ZACHARY PFISTER | — |
| BRIAN WILD | — |
Taxation/Internal Revenue Code TAX
Tax filing programs
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSEMARY BECCHI New | Tax Counsel, Senate Finance Committee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.